tiprankstipranks
Trending News
More News >
Inhibitor Therapeutics Inc. (INTI)
OTHER OTC:INTI
US Market

Compare Inhibitor Therapeutics (INTI) vs. Competitors

Compare
30 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibitor Therapeutics
$0.08
$13.43M
-3.87
35.09%
Kiora Pharmaceuticals
$1.91
$8.83M
-0.98
-39.85%
1 Buy
0 Hold
0 Sell
Moderate Buy
Genprex
$2.46
$6.17M
-0.06
-91.28%
Cyclerion Therapeutics
$1.37
$5.34M
-1.79
-46.46%
Artelo Biosciences
$1.24
$3.45M
-0.08
-75.64%
0 Buy
1 Hold
0 Sell
Hold
Dogwood Therapeutics
$3.15
$89.51M
-0.11
-78.13%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INTI
Inhibitor Therapeutics
0.08
0.02
35.09%
KPRX
Kiora Pharmaceuticals
2.40
-1.63
-40.45%
GNPX
Genprex
2.66
-28.27
-91.40%
CYCN
Cyclerion Therapeutics
1.36
-2.56
-65.31%
ARTL
Artelo Biosciences
1.71
-5.49
-76.25%
DWTX
Dogwood Therapeutics
2.79
-9.70
-77.66%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts